What is the clinical evidence for pygeum?

A 2002 Cochrane meta-analysis (Ishani et al.) of 18 RCTs (n=1562 total) found pygeum extract significantly improved overall urinary symptom measures, nocturia, peak urine flow, and residual urine volume vs placebo. Patients were twice as likely to report overall improvement. Effect sizes were moderate.

How much pygeum should I take?

Standardized pygeum bark extract: 75–200mg/day, typically divided into two doses. The most studied dose is 100mg/day (50mg twice daily). Look for extracts standardized to 13% total sterols.

Well-tolerated in clinical trials. Most common adverse effects: mild GI upset (nausea, stomach pain), abdominal cramping. Does not significantly affect PSA levels — no interference with prostate cancer screening. No significant drug interactions established.

Which prostate products contain pygeum?

FlowForce Max and Prostadine — both reviewed at BioBoostReviews — are formulated with pygeum bark extract.

Pygeum Bark Prostate Health Benefits Evidence 2026

Q: What does pygeum bark do for the prostate?

Pygeum africanum bark extract contains ferulic acid esters, phytosterols (including beta-sitosterol), and triterpenes. It reduces prostatic inflammation by inhibiting COX-2 and 5-LOX pathways, reduces growth factors that stimulate prostatic epithelial proliferation (EGF, IGF-1, bFGF), and may reduce DHT production via 5-AR inhibition.

Quick Answer: What Does the Science Say About Pygeum Bark?

Pygeum africanum bark extract has a strong clinical evidence base from a 2002 Cochrane meta-analysis of 18 RCTs (n=1562) showing significant improvements across multiple BPH symptom measures. Its mechanism is complementary to saw palmetto and beta-sitosterol — primarily anti-inflammatory and anti-proliferative rather than DHT-focused. Best used as part of a multi-botanical prostate formula.

What Is Pygeum Bark?

Pygeum africanum (African cherry) is an African tree whose bark has been used in traditional African medicine for urinary problems for centuries. The standardized lipophilic extract contains: ferulic acid esters (anti-inflammatory, reduces prolactin-stimulated prostatic growth), phytosterols (including beta-sitosterol), and pentacyclic triterpenes (anti-edema). Sourced from Cameroon and other Central African countries.

Mechanism of Action

Anti-inflammatory: Ferulic acid esters inhibit COX-2 and 5-LOX pathways, reducing prostatic inflammation. Inhibits arachidonic acid metabolism — reducing prostaglandins that stimulate prostatic smooth muscle contraction. Anti-proliferative: Reduces sensitivity of prostatic cells to growth factors (EGF, IGF-1, bFGF), slowing epithelial proliferation. Inhibits prolactin-stimulated prostatic growth — relevant because elevated prolactin drives BPH progression. Smooth muscle relaxation: Reduces alpha-adrenergic activity in prostatic smooth muscle, improving urinary flow. Phytosterol contribution: Beta-sitosterol content provides additional 5-AR inhibition.

Clinical Evidence

Cochrane Meta-Analysis (Ishani et al., 2002): 18 RCTs, n=1562. Pygeum significantly improved: overall symptom scores, nocturia (RR 0.68 for nocturia ≥2×/night), peak urine flow (+3.0 ml/s), residual urine volume (−24 ml). Patients were twice as likely to report overall improvement. Effect sizes were moderate but consistent across studies.

Evidence Gap: Most studies were short (≤24 weeks). Lack of standardized outcome measures across trials. Product quality varies widely — look for standardized extracts (13% total sterols). No direct comparison to pharmaceutical BPH treatment.

Dosage & Administration

Standard dose: 100–200mg/day of standardized extract (13% total sterols), divided into 2 doses. Take with meals. 4–8 weeks minimum for symptom assessment. Combination with saw palmetto and beta-sitosterol is common and mechanistically complementary.

Safety Profile

Well-tolerated. Mild GI adverse effects (nausea, stomach pain) most common — take with food. No significant PSA effect — does not interfere with prostate cancer screening. No significant drug interactions at standard doses. Long-term safety beyond 2 years not established.

BioBoost Verdict

Pygeum bark earns Strong ✅ (8/10) — tied with beta-sitosterol for the highest evidence score in our Prostate Ingredient category. The Cochrane meta-analysis (18 RCTs, 1562 patients) is the largest evidence base of any botanical in our 2026 Prostate category. Its anti-inflammatory + anti-proliferative mechanism complements saw palmetto’s DHT inhibition, making it particularly valuable in combination prostate formulas.

🛒 Products Containing Pygeum Bark

FlowForce Max Review — Multi-botanical with pygeum as primary anti-inflammatory
Prostadine Review — Pygeum + saw palmetto + zinc prostate formula

Frequently Asked Questions

What does pygeum bark do for the prostate?

Reduces prostatic inflammation (COX-2/5-LOX inhibition), reduces growth factor sensitivity in prostatic cells (anti-proliferative), relaxes prostatic smooth muscle, and contains beta-sitosterol for 5-AR inhibition.

What is the clinical evidence?

Cochrane 2002 (18 RCTs, n=1562): significant improvements in symptom scores, nocturia, peak flow, residual urine. Patients 2× more likely to report overall improvement.

Dosage?

100–200mg/day standardized extract (13% sterols). 2 doses with meals. 4–8 weeks minimum.

Does it affect PSA?

No significant PSA reduction — does not interfere with prostate cancer screening.

Which products contain it?

FlowForce Max and Prostadine — reviewed at BioBoostReviews.

Affiliate Disclosure: This page contains affiliate links. Analysis based on published clinical evidence only.